BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17002058)

  • 1. [Clarythromycin in the treatment of exacerbations of chronic obstructive lung disease].
    Shmelev EI; Ergeshev AE; Shmeleva NM; Sidorova VP
    Probl Tuberk Bolezn Legk; 2006; (8):42-7. PubMed ID: 17002058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease.
    Chelidze K; Jgarkava M
    Georgian Med News; 2008 Jun; (159):27-30. PubMed ID: 18633147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and economic analysis of antimicrobial therapy of chronic obstructive pulmonary disease exacerbations.
    Simoens S; Decramer M; De Coster S; Celis G; Laekeman G
    Int J Clin Pract; 2007 Feb; 61(2):200-6. PubMed ID: 17263707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inhalational antibacterial therapy for an exacerbation of chronic obstructive pulmonary disease].
    Nefedova MN; Shmelev EI
    Probl Tuberk Bolezn Legk; 2008; (8):8-11. PubMed ID: 18822473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of antibiotherapy in acute exacerbation of chronic obstructive pulmonary disease].
    Cavassini M; Calandra T; Bridevaux PO
    Rev Med Suisse; 2007 Apr; 3(106):939-42. PubMed ID: 17575969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
    File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
    Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the most appropriate antibiotics for the treatment of acute exacerbation of chronic obstructive pulmonary disease? A therapeutic outcomes model.
    Canut A; Martín-Herrero JE; Labora A; Maortua H
    J Antimicrob Chemother; 2007 Sep; 60(3):605-12. PubMed ID: 17595285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Answers to 5 common questions about acute exacerbations of COPD.
    Anzueto AR
    Postgrad Med; 2009 Sep; 121(5):159-65. PubMed ID: 19820285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)].
    Burgel PR
    Med Mal Infect; 2006; 36(11-12):706-17. PubMed ID: 16839731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
    Ruiz-González A; Giménez A; Gómez-Arbonés X; Soler-González J; Sánchez V; Falguera M; Porcel JM
    Respirology; 2007 Jan; 12(1):117-21. PubMed ID: 17207036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical inquiries: When are antibiotics indicated for acute COPD exacerbations?
    Balser E; Neher JO; Safranek S; Taraday J
    J Fam Pract; 2006 Dec; 55(12):1079-80. PubMed ID: 17137546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Practice guideline 'Medical treatment of COPD'].
    Dekhuijzen PN; Broeders ME; Tuut MK; Grol MH
    Ned Tijdschr Geneeskd; 2008 Jun; 152(26):1465-8. PubMed ID: 18666664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Exacerbation of chronic obstructive pulmonary disease: current approaches to antibacterial therapy].
    Sinopal'nikov AI; Guchev IA
    Klin Med (Mosk); 2002; 80(6):57-62. PubMed ID: 12138806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotics and reduced risk of COPD re-exacerbations.
    Antoniu SA
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):309-11. PubMed ID: 19670990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and outcome of severe chronic obstructive pulmonary disease exacerbations caused by multidrug-resistant bacteria.
    Nseir S; Ader F
    Curr Opin Pulm Med; 2008 Mar; 14(2):95-100. PubMed ID: 18303416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The problems of meta-analysis for antibiotic treatment of chronic obstructive pulmonary disease, a heterogeneous disease: a commentary on Puhan et al.
    Sethi S
    BMC Med; 2008 Oct; 6():29. PubMed ID: 18847482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Sethi S
    Semin Respir Crit Care Med; 2005 Apr; 26(2):192-203. PubMed ID: 16088436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Routine use of extended-release clarithromycin tablets for short-course treatment of acute exacerbations of non-severe COPD].
    Léophonte P; Zuck P; Perronne C; Baconnet B
    Med Mal Infect; 2008 Sep; 38(9):471-6. PubMed ID: 18722065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicomicrobiological monitoring of patients with exacerbation of chronic bronchitis treated with antibacterial drugs].
    Dvoretskiĭ LI; Dubrovskaia NV; Grudinina SA; Filimonova OIu; Iakovlev SV; Sergeeva EV; Sidorenko SV
    Ter Arkh; 2006; 78(3):25-35. PubMed ID: 17019954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.